Source: Annual Congress 2002 - Aspects of bronchopulmonary dysplasia
Disease area: Paediatric lung diseases, Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
T. A. Abd El Gawad, E. M. Fouda, M. M. Fatehy (Cairo, Egypt). Role of Ureaplasma urealyticum and Tumor necrosis factor alpha in chronic lung diseases of premature neonates. Eur Respir J 2002; 20: Suppl. 38, 3472

Member's Comments

No comment yet.

Related content which might interest you: Antenatal Ureaplasma urealyticum (Uu) respiratory tract infection stimulates pro-inflammatory, pro-fibrotic responses in the preterm baboon lung Source: Eur Respir J 2004; 24: Suppl. 48, 394s Year: 2004 Tumor necrosis factor α in chronic pulmonary diseases of children Source: Eur Respir J 2002; 20: Suppl. 38, 193s Year: 2002 Role of pulmonary infection in the development of chronic lung disease of prematurity Source: Eur Respir J 2011; 37: 1424-1430 Year: 2011 Ureaplasma in chronic lung disease of prematurity – strains, resistance and treatment Source: Annual Congress 2008 - Neonatal intensive care: ventilation and beyond Year: 2008 Epidermal growth factor in the lungs of infants developing chronic lung disease Source: Eur Respir J 2001; 18: 796-800 Year: 2001 Surfactant protein A (SP-A) enhances Ureaplasma urealyticum (Uu) killing and modulates the inflammatory cytokine response to Uu in RAW264.7 cells Source: Eur Respir J 2004; 24: Suppl. 48, 396s Year: 2004 Imbalance in the oral bacterial flora as a risk factor for acute exacerbation in idiopathic pulmonary fibrosis Source: International Congress 2019 – The evolving field of idiopathic interstitial pneumonia Year: 2019 Role of Bcl-xL in hepatocyte growth factor elicited epithelial protection in idiopathic lung fibrosis Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis Year: 2013 Pulmonary infections in patients receiving treatment of tumor necrosis factor alpha antagonists Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 Tumour necrosis factor gene polymorphisms and childhood wheezing Source: Eur Respir J 2005; 26: 637-646 Year: 2005 Chlamydia pneumoniae in children with chronic and recurrent bronchopulmonary diseases Source: Eur Respir J 2006; 28: Suppl. 50, 488s Year: 2006 Increased expression of tumor necrosis factor receptors by bronchoalveolar cells in cryptogenic organising pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 565s Year: 2006 Imbalanced secretion of IL-1β and IL-1RA in Chlamydia pneumoniae-infected mononuclear cells from COPD patients Source: Eur Respir J 2003; 22: 274-279 Year: 2003 Role of tumour necrosis factor-α receptor p75 in cigarette smoke-induced pulmonary inflammation and emphysema Source: Eur Respir J 2006; 28: 102-112 Year: 2006 Impact of prematurity on rabbit lung development: a key factor for mimicking chronic neonatal lung disease Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases Year: 2021 Transforming growth factor B1 polymorphism and serum levels in interstitial lung diseases Source: International Congress 2015 – New insights into IIPs Year: 2015 Cytokines in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 50S-59S Year: 2001 Dexamethasone treatment does not inhibit fibroproliferation in chronic lung disease of prematurity Source: Eur Respir J 2003; 21: 842-847 Year: 2003 Evidence of Ureaplasma urealyticum and Pneumocystis carinii very low birth weight infants with respiratory distress syndrome (RDS). A synergistic role? Source: Eur Respir J 2002; 20: Suppl. 38, 389s Year: 2002 Association of chronic Chlamydia pneumoniae infection of the risk of lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 322s Year: 2005